Ashvattha Therapeutics (“Ashvattha”), a clinical-stage company advancing a new class of nanomedicine therapeutics that traverse tissue barriers to selectively target and reprogram activated cells in ...
David Norton, one of four finalists in the search for the U of A's next provost, will present his vision for the U of A, discuss experiences that have prepared him for this role and answer audience ...